KOMISJA NADZORU FINANSOWEGO | ||||||||||||
Raport bieżący nr | 4 | / | 2019 | |||||||||
Data sporządzenia: | 2019-10-04 | |||||||||||
Skrócona nazwa emitenta | ||||||||||||
MILESTONE MEDICAL | ||||||||||||
Temat | ||||||||||||
List of Shareholders representing at least 5% of the number of votes at the Annual General Meeting of the Shareholders on October 3, 2019 | ||||||||||||
Podstawa prawna | ||||||||||||
Art. 70 pkt 3 Ustawy o ofercie - WZA lista powyżej 5 % | ||||||||||||
Treść raportu: | ||||||||||||
The Board of Directors of Milestone Medical Inc, (“the "Company”,"the Issuer") hereby informs that the entities named below were shareholders representing at least 5% of the number of votes at the Annual General Meeting of Shareholders held in Livingston, New Jersey, USA, on October 3, 2019 “the Meeting" - Milestone Scientific Inc.- the shares held in the Company vested in Milestone Scientific the right of 21,633,084 votes at the Meeting, which accounted for 100% of the votes of the Shareholders present at the Meeting and for 98.33% of the total number of votes. |
MESSAGE (ENGLISH VERSION) |
MILESTONE MEDICAL INC | ||||||||||||||||
(pełna nazwa emitenta) | ||||||||||||||||
MILESTONE MEDICAL | ||||||||||||||||
(skrócona nazwa emitenta) | (sektor wg. klasyfikacji GPW w W-wie) | |||||||||||||||
NJ 07039 | . | |||||||||||||||
(kod pocztowy) | (miejscowość) | |||||||||||||||
South Orange Avenue Livingston | 220 | |||||||||||||||
(ulica) | (numer) | |||||||||||||||
+11 973 535 2717 | +11 973 535 2829 | |||||||||||||||
(telefon) | (fax) | |||||||||||||||
(e-mail) | (www) | |||||||||||||||
27-5484393 | ||||||||||||||||
(NIP) | (REGON) |
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
2019-10-04 | Joseph D'Agostino | Chief Financial Officer | Joseph D'Agostino |